Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 174Squamous Cell Carcinoma of Head and Neck 147Nasopharyngeal Carcinoma 126Oropharyngeal Neoplasms 25Thyroid Neoplasms 23Nasopharyngeal Neoplasms 21Mouth Neoplasms 21Carcinoma, Squamous Cell 19Laryngeal Neoplasms 17Neoplasms 15Radiation Injuries 13Hypopharyngeal Neoplasms 13Salivary Gland Neoplasms 11Carcinoma 11Stomatitis 10Recurrence 10Laryngeal Diseases 10Tongue Neoplasms 9Mucositis 8Parkinson Disease 4, Autosomal Dominant Lewy Body 7Pain 7Neoplasm Metastasis 7Esthesioneuroblastoma, Olfactory 7Xerostomia 6Uterine Cervical Neoplasms 6Differentiated Thyroid Cancer 6Breast Neoplasms 6Thyroid Cancer, Papillary 5Parathyroid Neoplasms 4Melanoma 4

Interventions

Allovectin-7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Otorhinolaryngologic Neoplasms × Head & Neck × Clear all
NCT00050388 2008-06-24

Phase II Trial of Allovectin-7® for Head and Neck Cancer

Vical

Phase 3 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Head and Neck Neoplasms, Laryngeal Diseases, Lip Neoplasms, Neoplasms, Otorhinolaryngologic Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡